retatrutide companies Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more at our link in bio RETATRUTIDE (RETA) – Research Peptide

In my experience, bad breath isn't one of the most common complaints with GLP-1 medications, but it does come up occasionally

This sends a signal of fullness to the brain, which in turn suppresses feelings of hunger

Common gastrointestinal side effects that are especially severe or do not resolve within a few weeks, such as nausea, diarrhea, constipation, or vomiting, are also common reasons for stopping the medication

Nagell CF, Wettergren A, Pedersen JF, Mortensen D, Holst JJ (2004) Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1

Who should consider a medical evaluation before focusing on weight loss

Mowed yard and while my eyes were itchy from the grass my nose throat and chest stayed clear